Over the past two years, the Food and Drug Administration has announced dozens of recalls of all prescription and
over-the-counter Ranitidine drugs, including Zantac from the market. The FDA claims the makers of Zantac failed to warn users the drug can produce unsafe levels of N-Nitrosodimethylamine, better known as NDMA, which is classified as a probable human carcinogen. Zantac was once a popular anti-heartburn medication.
If you ever took Zantac or know someone who took Zantac and then developed cancer, you/they may qualify for a potential compensation claim. We are bringing compensation claims on behalf of Zantac users.
Some of the Cancers Linked to Zantac: